Evidence map›Paper›PMID 32868886›Full record

ArticleNature chemistry2020

Using sulfuramidimidoyl fluorides that undergo sulfur(VI) fluoride exchange for inverse drug discovery.

Gabriel J Brighty, Rachel C Botham, Suhua Li, Luke Nelson, David E Mortenson, Gencheng Li, Christophe Morisseau, Hua Wang, Bruce D Hammock, K Barry Sharpless and 1 more

Abstract read
In one paragraph

Article in Nature chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Multimodal S(VI) Exchange Click Reactions Derived from SFThe Journal of organic chemistry · 2025
    Article
  7. Review
  8. Review
  9. Diversity Oriented Clicking for Modular Synthesis.Nature reviews. Methods primers · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Gabriel J Brighty *Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Rachel C Botham *Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Suhua Li *Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5489-8643
Luke NelsonDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
David E MortensonDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Gencheng LiDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Christophe MorisseauDepartment of Entomology and Nematology, University of California Davis, Davis, CA, USA.
Hua WangDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Bruce D HammockDepartment of Entomology and Nematology, University of California Davis, Davis, CA, USA.
K Barry SharplessDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA. sharples@scripps.edu.ORCID http://orcid.org/0000-0001-6051-1599
Jeffery W KellyDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA. jkelly@scripps.edu.ORCID http://orcid.org/0000-0001-8943-3395

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Probing the Biochemical Mechanisms of Amyloid DiseaseR01DK046335 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI KELLY, JEFFERY W · 1998 to 2025
$8.8M
Probing the biochemical mechanism of amyloid diseaseR37DK046335 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI KELLY, JEFFERY W · 2006 to 2015
$5.9M
Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human healthR35ES030443 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORISSEAU, CHRISTOPHE HP · 2019 to 2025
$5.8M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
NIDDK NIH HHS R01 DK046335NIDDK NIH HHS R37 DK046335NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R01 ES002710NIEHS NIH HHS R35 ES030443
6 · The paper itself

Abstract

Drug candidates that form covalent linkages with their target proteins have been underexplored compared with the conventional counterparts that modulate biological function by reversibly binding to proteins, in part due to concerns about off-target reactivity. However, toxicity linked to off-target reactivity can be minimized by using latent electrophiles that only become activated towards covalent bond formation on binding a specific protein. Here we study sulfuramidimidoyl fluorides, a class of weak electrophiles that undergo sulfur(VI) fluoride exchange chemistry. We show that equilibrium binding of a sulfuramidimidoyl fluoride to a protein can allow nucleophilic attack by a specific amino acid side chain, which leads to conjugate formation. We incubated small molecules, each bearing a sulfuramidimidoyl fluoride electrophile, with human cell lysate, and the protein conjugates formed were identified by affinity chromatography-mass spectrometry. This inverse drug discovery approach identified a compound that covalently binds to and irreversibly inhibits the activity of poly(ADP-ribose) polymerase 1, an important anticancer target in living cells.

Indexed as

Drug DiscoveryChromatography, AffinityFluoridesHEK293 CellsHumansMass SpectrometryMolecular StructureSulfhydryl CompoundsSulfurFluoridesSulfhydryl CompoundsSulfur

Identifiers

PMID32868886
PMCPMC7541551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.